NCT00061763 - Study of Deferasirox in Iron Overload From Beta-thalassemia Unable to be Treated With Deferoxamine or Chronic Anemias | Biotech Hunter

Enrollment

175

Participants

Timeline

Start Date

May 31, 2003

Primary Completion Date

November 30, 2004

Conditions

Beta-thalassemiaMyelodysplastic SyndromesFanconi SyndromeAnemia, Diamond-BlackfanAnemia, Aplastic

Interventions

DRUG

Deferasirox

Trial Locations (6)

Weill Medical College of Cornell University, New York

Northwest Medical Specialists, Arlington Heights

Children's Hospital Oakland, Oakland

Stanford Hospital, Stanford

Children's Hospital Boston, Boston

Children's Hospital of Philadelphia, Philadelphia